Want to stay abreast of changes in prevention, care, treatment or research or other public health arenas that affect our collective response to the HIV epidemic? Or are you new to this field?
HIV.gov curates learning opportunities for you, and the people you serve and collaborate with.
Stay up to date with the webinars, Twitter chats, conferences and more in this section.
09-18-2024NIH s National Institute of Allergy and Infectious Diseases has recently shared news about mpox research, HIV risk among cisgender women, COVID in people with..…
07-26-2024Kaye Hayes, HHS Deputy Assistant Secretary for Infectious Disease and Director of the Office of Infectious Disease and HIV/AIDS Policy, and Francisco Ruiz, Dire…
07-25-2024HIV.gov continues its daily livestreams from the International AIDS Conference in Munich, Germany. Today s topics include long-acting injectables, bi-directio..…
06-05-2024Louis Shackelford of the HIV Vaccine Trials Network and NIH s Carl Dieffenbach discuss why a safe, effective, and durable HIV vaccine is important for health...
05-16-2024The STOMP trial is evaluating the antiviral drug tecovirimat (TPOXX) as a treatment for mpox. Learn how individuals, providers, and community organizations can.…
04-24-2024Cross-posted from: NIAID Now Blog The HIV research community is led by scientists with deep personal commitments to improving the lives of people with and affe.…
03-08-2024On Wednesday as the 2024 Conference on Retroviruses and Opportunistic Infections (CROI) was winding down, HIV.gov spoke with NIH s Dr. Carl Dieffenbach about...
03-07-2024On the final day of the 2024 Conference on Retroviruses and Opportunistic Infections (CROI), HIV.gov spoke with Deborah Persaud, MD, Professor of Pediatrics at.…
